Search All News
In a new study of mice, Columbia researchers found that an experimental drug that breaks down an amino acid slows pancreatic tumor growth by causing ferroptosis, an unusual form of cell death.
CancerFIT—a free exercise program at CUIMC for cancer patients and survivors—offers more than a physical workout, it also provides much-needed support and inspiration.
Columbia biomedical engineers have designed a bacteria strain that seeks out solid tumors and safely delivers immunotherapies, resulting in tumor regression in mouse models.
The three scientists honored by the 2019 Horwitz Prize played key roles in identifying and deciphering the PI3K pathway, which has led to new treatments for several types of cancer.
- May 12, 2014
Two genes together drive the most lethal forms of prostate cancer; could lead to diagnostic test and new treatments.
- April 18, 2014
New bone marrow transplant unit specializes in cutting-edge treatments for blood cancers and autoimmune diseases.
- April 9, 2014
Important tips on sunglasses and sun exposure from NewYork-Presbyterian Hospital experts.
- April 3, 2014
Alfred Neugut, MD, PhD, says it may be time to make aspirin a part of the conventional standard of care for colon cancer.
- March 26, 2014
Early detection of retinoblastoma in children does not improve outcomes, suggests a Mailman study.
- February 20, 2014
The American Medical Association has honored P&S student Gregory Joice for his research.
- January 23, 2014
Breast cancer study in mice suggests that radiation therapy to unaffected breast could reduce risk of second cancer.
- January 21, 2014
Common type of leukemia may start with a change in bone cells.
- January 6, 2014
NewYork-Presbyterian/Columbia University Medical Center has named leading physician-scientist Dr. Gary Schwartz chief of the Division of Hematology/Oncology in the Department of Medicine and associate director for research of its Herbert Irving Comprehensive Cancer Center.